Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...

Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Alpaca Real Estate (“ARE”), an alternative investment management firm, closed a $50 million credit facility with Stifel Bank. This financing marks another key milestone in the firm’s growth, ...